Atypical Teratoid/Rhabdoid Tumor Clinical Trials
2 recruiting trials for Atypical Teratoid/Rhabdoid Tumor. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT06465199
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been...
Sponsor: Milton S. Hershey Medical CenterEnrolling: 2896 locations
RECRUITINGPhase 1 / Phase 2NCT05407441
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
This research study involves a combination of three drugs given together as a possible treatment for malignant rhabdoid tumor, atypical teratoid rhabdoid tumor, epithelioid...
Sponsor: Susan Chi, MDEnrolling: 493 locations